The overall value of exported antibiotics rose by an average 5.6% for exporting countries 5 years earlier in 2020 when antibiotics shipments were valued at $9.96 billion.
Year over year, the value of globally exported antibiotics flatlined to a 0.5% gain compared to $10.46 billion starting from 2023.
Technically classified as organic chemicals, antibiotics are medicaments used to fight, treat and prevent bacterial infections. Contrary to popular perception, antibiotics fail to inhibit influenza, the common cold and other viruses. In short, antibiotics are not antiviral drugs.
The 5 biggest suppliers of antibiotics on international markets are mainland China, India, Switzerland, Italy and the United States of America. Combined, that quintet of leading antibiotics exporters generated about three-quarters (74.6%) of world antibiotics shipments for 2024.
Applying a continental lens, suppliers in Asia sold the highest dollar worth of exported antibiotics during 2024 with shipments valued at $5.8 billion or 55.4% of the global total. In second place were exporters located in Europe at 34.6%.
Smaller percentages originated from sellers in North America (7.4%), Latin America (2.5%) excluding Mexico but including the Caribbean, Oceania (0.1%) mostly New Zealand and Australia, then providers in Africa (0.02%).
For research purposes, the 4-digit Harmonized Tariff System code prefix is 2609 for antibiotics.
Top Antibiotics Exporters
Below are the 20 countries that exported the highest dollar value worth of antibiotics during 2024.
- mainland China: US$4.3 billion (41% of overall exported antibiotics)
- India: $1.1 billion (10.2%)
- Switzerland: $867.4 million (8.2%)
- Italy: $854.5 million (8.1%)
- United States: $736.5 million (7%)
- Belgium: $489.1 million (4.7%)
- Spain: $408.2 million (3.9%)
- Panama: $205.2 million (2%)
- Denmark: $187.6 million (1.8%)
- South Korea: $173 million (1.6%)
- France: $127.9 million (1.2%)
- Netherlands: $114.2 million (1.1%)
- Austria: $99.4 million (0.9%)
- Germany: $98.7 million (0.9%)
- Singapore: $94.4 million (0.9%)
- Hungary: $88 million (0.8%)
- Japan: $86.8 million (0.8%)
- Ireland: $63.8 million (0.6%)
- Brazil: $57 million (0.5%)
- Portugal: $41.5 million (0.4%)
By value, the listed 20 countries shipped 96.8% of worldwide export sales for antibiotics in 2024.
Among the top exporters, the fastest-growing antibiotics exporters since 2023 were: Ireland (up 83.5%), Belgium (up 17.8%), Switzerland (up 15.7%) and Germany (up 10.6%).
Listed suppliers that posted the severest percentage declines in their exported antibiotics sales were led by: Singapore (down -41.3% from 2023), United States of America (down -31.7%), Portugal (down -22.9%) and Hungary (down -16.5%).
Countries with Best Competitive Trade Advantages
The listed countries posted positive net exports for antibiotics during 2024.
Investopedia defines net exports as the value of a country’s total exports minus the value of its total imports. Thus, the statistics below present the surplus between the value of each country’s exported antibiotics and its import purchases for that same commodity.
- mainland China: US$3.7 billion (net export surplus (up 2.6% since 2023)
- Switzerland: $703.4 million (up 22%)
- Belgium: $173.5 million (up 310.5%)
- Denmark: $154 million (down -13%)
- Spain: $115.6 million (up 93.7%)
- Singapore: $82.5 million (down -47.1%)
- Hungary: $73.9 million (down -22.3%)
- United States: $20.8 million (down -94.2%)
- Slovakia: $6.1 million (down -45.5%)
- Malta: $3.7 million (down -48.9%)
- New Zealand: $2.3 million (reversing a -$459,000 deficit)
- Croatia: $2.3 million (reversing a -$2.7 million deficit)
- Sweden: $1.5 million (reversing a -$5.5 million deficit)
- Czech Republic: $556,000 (reversing a -$6.2 million deficit)
- Sierra Leone: $142,000 (up 491.7%)
Mainland China generated the highest surplus in the international trade of antibiotics. In turn, this positive cashflow confirms China’s strong competitive advantage for this specific product category.
Countries with Worst Competitive Trade Disadvantages
The following countries posted the highest negative net exports for antibiotics during 2024.
Investopedia defines net exports as the value of a country’s total exports minus the value of its total imports. Thus, the statistics below present the deficit between the value of each country’s imported antibiotics purchases and its exports for that same commodity.
- India: -US$870.9 million (net export deficit (down -9% since 2023)
- Italy: -$372 million (up 61.9%)
- Vietnam: -$330.9 million (up 5.2%)
- Brazil: -$318.7 million (up 6.4%)
- France: -$297.6 million (down -25.1%)
- Germany: -$234.8 million (down -12.5%)
- Türkiye: -$214.5 million (down -1.3%)
- Egypt: -$199 million (up 57.7%)
- Bangladesh: -$195.5 million (up 13.3%)
- Japan: -$190.4 million (up 15.6%)
- Indonesia: -$171.8 million (up 7.6%)
- Pakistan: -$158.4 million (up 26.2%)
- Canada: -$155.7 million (up 4.9%)
- United Kingdom: -$148.7 million (down -8.2%)
- Russia: -$135.3 million (up 2.3%)
Highly populated India recorded the highest deficit in the international trade of antibiotics. In turn, this negative cashflow highlights the strong Indian competitive disadvantage for this specific product category but also signals opportunities for antibiotics-supplying countries that help satisfy the powerful demand.
Antibiotics Exporting Companies
Below are 3 of America’s biggest pharmaceutical businesses. Also shown is the city where the headquarters for each company.
This trio of Big Pharma companies banded together in 2024. The goal of this collective effort is to develop new antibiotics via a $1 billion AMR Action Fund.
- Pfizer (New York, New York)
- Johnson & Johnson (New Brunswick, New Jersey)
- Merck (Kenilworth, New Jersey)
Two to four newly developed antibiotics are anticipated by 2030.
See also Drugs and Medicines Exports by Country, Heart Pacemaker Export Sales by Country and Top Blood Exporters by Country
Research Sources:
Central Intelligence Agency, The World Factbook Field Listing: Exports – Commodities. Accessed on February 4, 2026
Fierce Biotech, Big Pharma joins forces on $1B fund to shore up struggling antibiotics makers. Accessed on February 4, 2026
Forbes Global 2000 rankings, The World’s Biggest Public Companies. Accessed on February 4, 2026
International Trade Centre, Trade Map. Accessed on February 4, 2026
Investopedia, Net Exports Definition. Accessed on February 4, 2026
Statistica (The Statistics Portal), Leading antibiotics producing companies worldwide in 2020. Accessed on February 4, 2026
Wikipedia, Antibiotic. Accessed on February 4, 2026